QAAGZX Holdings — T. Rowe Price Health Sciences Portfolio
All 285 reported holdings of T. Rowe Price Health Sciences Portfolio (QAAGZX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 10.21% | $67.69M |
| Thermo Fisher Scientific, Inc. | 4.08% | $27.01M |
| Intuitive Surgical, Inc. | 3.68% | $24.40M |
| Stryker Corp. | 3.49% | $23.12M |
| Merck & Co. Inc. | 3.46% | $22.91M |
| Astrazeneca PLC | 3.18% | $21.05M |
| Unitedhealth Group, Inc. | 3.10% | $20.54M |
| Argenx SE - ADR | 2.93% | $19.39M |
| Abbvie, Inc. | 2.88% | $19.08M |
| Regeneron Pharmaceuticals | 2.68% | $17.77M |
| Gilead Sciences, Inc. | 2.61% | $17.29M |
| Johnson & Johnson | 2.46% | $16.28M |
| Vertex Pharmaceuticals, Inc. | 2.43% | $16.10M |
| Danaher Corp. | 2.05% | $13.59M |
| Alnylam Pharmaceuticals, Inc. | 1.63% | $10.80M |
| Ascendis Pharma A/s - ADR | 1.42% | $9.40M |
| Revolution Medicines, Inc. | 1.36% | $8.98M |
| United Therapeutics Corp. | 1.35% | $8.95M |
| Beone Medicines Ltd. | 1.20% | $7.98M |
| Roivant Sciences Ltd. | 1.13% | $7.51M |
| Protagonist Therapeutics, Inc. | 1.11% | $7.34M |
| Insmed, Inc. | 1.06% | $7.05M |
| Natera, Inc. | 1.06% | $7.04M |
| Summit Therapeutics, Inc. | 1.04% | $6.88M |
| Tenet Healthcare Corp. | 1.03% | $6.80M |
| Brightspring Health Services | 0.99% | $6.57M |
| Amgen, Inc. | 0.99% | $6.53M |
| Boston Scientific Corp. | 0.93% | $6.14M |
| Hca Healthcare, Inc. | 0.92% | $6.08M |
| Guardant Health, Inc. | 0.92% | $6.06M |
| Cvs Health Corp. | 0.86% | $5.69M |
| Kymera Therapeutics, Inc. | 0.77% | $5.09M |
| Cigna Group/the | 0.75% | $4.97M |
| Cg Oncology, Inc. | 0.71% | $4.71M |
| Cardinal Health, Inc. | 0.69% | $4.56M |
| Elevance Health, Inc. | 0.67% | $4.41M |
| Krystal Biotech, Inc. | 0.66% | $4.39M |
| Ionis Pharmaceuticals, Inc. | 0.63% | $4.16M |
| Scholar Rock Holding Corp. | 0.62% | $4.13M |
| Bridgebio Pharma, Inc. | 0.60% | $3.97M |
| Chugai Pharmaceutical Co. Ltd. | 0.58% | $3.85M |
| Structure Therapeutics, Inc. ADR | 0.56% | $3.74M |
| Praxis Precision Medicines I | 0.56% | $3.73M |
| Celcuity, Inc. | 0.56% | $3.72M |
| Royalty Pharma PLC- Cl A | 0.56% | $3.70M |
| Cencora, Inc. | 0.53% | $3.51M |
| Centessa Pharmaceuticals-ADR | 0.50% | $3.31M |
| Vera Therapeutics, Inc. | 0.47% | $3.11M |
| Nuvalent, Inc.-A | 0.45% | $2.97M |
| T. Rowe Price Government Reserve Fund | 0.44% | $2.94M |
| Apogee Therapeutics, Inc. | 0.44% | $2.93M |
| Abivax SA-ADR | 0.42% | $2.78M |
| Edwards Lifesciences Corp. | 0.41% | $2.75M |
| Cytokinetics, Inc. | 0.40% | $2.68M |
| Incyte Corp. | 0.40% | $2.66M |
| Spyre Therapeutics Inc | 0.40% | $2.66M |
| Dianthus Therapeutics, Inc. | 0.37% | $2.48M |
| Crinetics Pharmaceuticals In | 0.37% | $2.42M |
| Tenax Therapeutics, Inc. | 0.37% | $2.42M |
| Madrigal Pharmaceuticals, Inc. | 0.36% | $2.39M |
| Immunome, Inc. | 0.35% | $2.35M |
| Iqvia Holdings, Inc. | 0.34% | $2.23M |
| Kodiak Sciences, Inc. | 0.32% | $2.14M |
| Caris Life Sciences, Inc. | 0.31% | $2.08M |
| Belite Bio, Inc. - ADR | 0.31% | $2.02M |
| Monte Rosa Therapeutics, Inc. | 0.28% | $1.84M |
| Terns Pharmaceuticals, Inc. | 0.27% | $1.79M |
| Axsome Therapeutics, Inc. | 0.26% | $1.70M |
| Alignment Healthcare, Inc. | 0.25% | $1.66M |
| Moderna Therapeutics, Inc. | 0.25% | $1.64M |
| Alumis, Inc. | 0.24% | $1.60M |
| Beam Therapeutics, Inc. | 0.24% | $1.59M |
| Revvity, Inc. | 0.23% | $1.53M |
| West Pharmaceutical Services | 0.23% | $1.50M |
| Sonova Holding AG-Reg | 0.22% | $1.47M |
| Idexx Laboratories, Inc. | 0.22% | $1.47M |
| Sionna Therapeutics, Inc. | 0.22% | $1.43M |
| Oruka Therapeutics, Inc. | 0.21% | $1.42M |
| Oric Pharmaceuticals, Inc. | 0.21% | $1.40M |
| Mckesson Corp. | 0.20% | $1.34M |
| Mbx Biosciences, Inc. | 0.20% | $1.31M |
| Mirum Pharmaceuticals, Inc. | 0.20% | $1.30M |
| Billiontoone, Inc. Cl A | 0.19% | $1.28M |
| Rhythm Pharmaceuticals, Inc. | 0.19% | $1.28M |
| Erasca, Inc. | 0.19% | $1.23M |
| National Resilience Sr B Cvt Pfd Stk Pp | 0.18% | $1.19M |
| Arrowhead Pharmaceuticals, Inc. | 0.18% | $1.19M |
| Immunocore Holdings PLC-ADR | 0.18% | $1.18M |
| Palvella Therapeutics, Inc. | 0.18% | $1.18M |
| Rapport Therapeutics, Inc. | 0.18% | $1.16M |
| Nurix Therapeutics, Inc. | 0.17% | $1.14M |
| Vaxcyte, Inc. | 0.17% | $1.12M |
| Centene Corp. | 0.16% | $1.04M |
| Bio-Rad Laboratories-A | 0.16% | $1.03M |
| Novo-Nordisk A/s-Spons ADR | 0.15% | $1.02M |
| Moonlake Immunotherapeutics | 0.15% | $1.01M |
| Kestra Medical Technologies | 0.15% | $972.11K |
| Wave Life Sciences Ltd. | 0.14% | $931.79K |
| Encompass Health Corp. | 0.14% | $928.90K |
| Stoke Therapeutics, Inc. | 0.14% | $911.68K |
| Treeline Bio Ser A-1 Cvt Pfd Stock Pp | 0.14% | $896.73K |
| Beone Medicines Ltd.-ADR | 0.13% | $884.97K |
| Charles River Laboratories | 0.13% | $845.25K |
| Celldex Therapeutics, Inc. | 0.13% | $838.36K |
| Generate Biomedicines Inc Lockup Shs PP | 0.13% | $835.14K |
| Bicara Therapeutics, Inc. | 0.12% | $827.40K |
| Tango Therapeutics, Inc. | 0.12% | $813.79K |
| Relay Therapeutics, Inc. | 0.12% | $800.17K |
| Cogent Biosciences, Inc. | 0.12% | $793.32K |
| Repligen Corp. | 0.12% | $789.98K |
| Viatris, Inc. | 0.12% | $786.28K |
| Cellanome Series A Cvt Pfd Stock Pp | 0.12% | $781.60K |
| Tarsus Pharmaceuticals, Inc. | 0.12% | $777.05K |
| Treeline Bio Ser A Cvt Pfd Stock Pp | 0.12% | $772.87K |
| Ocular Therapeutix, Inc. | 0.11% | $757.22K |
| Molina Healthcare, Inc. | 0.11% | $740.61K |
| Replimune Group, Inc. | 0.11% | $736.44K |
| Disc Medicine, Inc. | 0.11% | $730.39K |
| Insitro Ser B Cvt Pfd Pp | 0.11% | $727.86K |
| Tyra Biosciences, Inc. | 0.11% | $720.04K |
| Corvus Pharmaceuticals, Inc. | 0.11% | $713.42K |
| Kyverna Therapeutics, Inc. | 0.11% | $696.21K |
| Sartorius AG-Vorzug Pref | 0.10% | $679.34K |
| Galvanize Thera Ser C-1 Cvt Pfd Pp | 0.10% | $678.96K |
| Medpace Holdings, Inc. | 0.10% | $672.27K |
| Immunocore Holdings Cb 2.50% 2/30 | 0.10% | $666.25K |
| Biohaven Ltd. | 0.10% | $660.67K |
| Arsenal Biosciences Ser C Cvt Pfd Pp | 0.10% | $650.73K |
| Climb Bio Inc | 0.10% | $638.42K |
| Aktis Oncology Inc. Lockup Shs PP | 0.10% | $632.38K |
| Cullinan Therapeutics Inc | 0.09% | $609.61K |
| Olema Pharmaceuticals, Inc. | 0.09% | $606.79K |
| Delfi Diagnostics Sr A Cvt Pfd Stock Pp | 0.09% | $604.19K |
| Liquidia Corp. | 0.09% | $598.33K |
| Allogene Therapeutics, Inc. | 0.09% | $593.57K |
| Ideaya Biosciences, Inc. | 0.09% | $585.47K |
| Pharvaris NV | 0.09% | $581.50K |
| Lantheus Holdings, Inc. | 0.09% | $568.88K |
| Denali Therapeutics, Inc. | 0.09% | $563.52K |
| Atrium Therapeutics, Inc. | 0.08% | $557.53K |
| Shattuck Labs, Inc. | 0.08% | $549.76K |
| Endeavor Bio Series B Cvt Pfd Stock Pp | 0.08% | $550.05K |
| Clear Labs Series C Cvt Pfd Pp | 0.08% | $542.40K |
| Seaport Therapeutics Ser B Cvt Pfd Pp | 0.08% | $539.70K |
| Kailera Therapeutics SER B CVT PFD PP | 0.08% | $512.47K |
| Third Arc Bio Ser A Cvt Pfd Pp | 0.08% | $505.10K |
| Sensorion SA | 0.07% | $488.84K |
| Kartos Therapeutics Sr C Cvt Pfd Stk Pp | 0.07% | $485.75K |
| Insitro Ser C Cvt Pfd Pp | 0.07% | $480.73K |
| Mirum Pharma 6 month Lockup Shs PP | 0.07% | $475.31K |
| Mirum Pharma 9 month Lockup Shs PP | 0.07% | $475.40K |
| Cleerly Ser C Cvt Pfd Stk Pp | 0.07% | $465.65K |
| Genesis Molecular AI Ser B CVT PFD PP | 0.07% | $465.32K |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | 0.07% | $460.45K |
| Spyglass Pharma, Inc. | 0.07% | $452.13K |
| Procept Biorobotics Corp. | 0.07% | $448.70K |
| Iovance Biotherapeutics, Inc. | 0.07% | $448.75K |
| Obsidian Therapeutic Sr C Cvt Pfd Stk Pp | 0.06% | $422.06K |
| National Resilience Sr C Cvt Pfd Stk Pp | 0.06% | $420.43K |
| Viridian Therapeutics, Inc. | 0.06% | $409.43K |
| Immatics NV | 0.06% | $378.84K |
| Kardium Inc Series D-7 CVT PFD Stock PP | 0.06% | $378.06K |
| Evommune, Inc. | 0.06% | $375.86K |
| Inspire Medical Systems, Inc. | 0.06% | $371.38K |
| Parabilis Med, Inc. Ser F Cvt Pfd Pp | 0.06% | $370.14K |
| Alto Neuroscience, Inc. | 0.06% | $368.67K |
| Aktis Oncology, Inc. | 0.05% | $358.03K |
| Nchroma Bio Ser I Cvt Pfd Stock Pp | 0.05% | $355.00K |
| Kardium, Inc. Ser D-5 Cvt Pfd Stock Pp | 0.05% | $330.77K |
| Delfi Diagnostics Sr B Cvt Pfd Stock Pp | 0.05% | $328.85K |
| Crescent Biopharma, Inc. | 0.05% | $323.88K |
| Avalyn Pharma Ser C-1 Cvt Pfd Stock Pp | 0.05% | $309.44K |
| Galvanize Therapeutics Ser C CVT PFD PP | 0.05% | $304.54K |
| Bicycle Therapeutics PLC-ADR | 0.04% | $291.61K |
| Scribe Thera Ser B Cvt Pfd Stock Pp | 0.04% | $277.64K |
| Xencor, Inc. | 0.04% | $275.61K |
| Immuneering Corp. - Class A | 0.04% | $273.27K |
| Color Health Sr D-1 Cvt Pfd Stock Pp | 0.04% | $271.82K |
| Element Biosciences Ser C Cvt Pfd Stock Pp | 0.04% | $266.07K |
| Deepsight Tech Inc SER C CVT PFD PP | 0.04% | $264.30K |
| Zai Lab Ltd. ADR | 0.04% | $259.15K |
| SPAC PCSC Freenome PIPE COMMIT PP | 0.04% | $257.59K |
| Color Health Sr D Cvt Pfd Stock Pp | 0.04% | $255.42K |
| Entrada Therapeutics, Inc. | 0.04% | $254.41K |
| Kardium Inc Series D-8 CVT PFD Stock PP | 0.04% | $241.59K |
| Tectonic Therapeutic, Inc. | 0.04% | $234.92K |
| Eikon Therapeutics, Inc. | 0.03% | $221.93K |
| Freenome Holdings Ser B Cvt Pfd Pp | 0.03% | $208.44K |
| Generate Biomedicines, Inc. | 0.03% | $200.54K |
| Parabilis Med, Inc. Ser D Cvt Pfd Stock Pp | 0.03% | $200.19K |
| Genesis Molecular AI Ser A CVT PFD PP | 0.03% | $191.39K |
| BridgeBio Oncology Therapeutics Inc | 0.03% | $190.21K |
| Parabilis Med, Inc. Ser E Cvt Pfd Stock Pp | 0.03% | $183.75K |
| Immix Biopharma, Inc. | 0.03% | $182.20K |
| Eikon Therapeutics, Inc Lockup Shs PP | 0.03% | $177.12K |
| Evommune, Inc. Pipe Pp | 0.02% | $165.25K |
| Parabilis Med, Inc. Ser C Cvt Pfd Stock Pp | 0.02% | $163.68K |
| Manus Bio, Inc. Series One-6 Cvt Pfd Pp | 0.02% | $163.49K |
| Tessera Therapeutics Ser C' Cvt Pfd Pp | 0.02% | $157.67K |
| Endeavor Bio Ser C Cvt Pfd Pp | 0.02% | $154.16K |
| Kartos Therapeutics SR D CVT PFD STK PP | 0.02% | $153.12K |
| Agios Pharmaceuticals, Inc. | 0.02% | $147.40K |
| Hims & Hers Health, Inc. | 0.02% | $134.94K |
| Saluda Medical, Inc. | 0.02% | $134.56K |
| Aura Biosciences, Inc. | 0.02% | $134.27K |
| Rocket Pharmaceuticals, Inc. | 0.02% | $130.54K |
| Enliven Therapeutics, Inc. | 0.02% | $129.36K |
| Arbor Bio Series B Cvt Pfd Stock Pp | 0.02% | $127.65K |
| Immunovant, Inc. | 0.02% | $126.68K |
| Treeline Bio SER A-2 CVT PFD PP | 0.02% | $126.52K |
| Freenome Holdings Ser C Cvt Pfd Pp | 0.02% | $121.83K |
| Monopar Therapeutics, Inc. | 0.02% | $119.72K |
| Cabaletta Bio, Inc. | 0.02% | $119.66K |
| Pax Labs Class A Common Pp | 0.02% | $119.56K |
| Lumicks Tech Ser D Cvt Pfd Stock Pp | 0.02% | $119.11K |
| Dna Script Series C Cvt Pfd Stock Pp | 0.02% | $117.23K |
| Annexon, Inc. | 0.02% | $113.44K |
| Saluda Medical Inc Lockup Shs CDI PP | 0.02% | $107.19K |
| Mirum Pharma Indemnity Holdback Shs PP | 0.02% | $106.19K |
| Adlai Nortye Ltd.-ADR | 0.01% | $92.86K |
| Lenz Therapeutics, Inc. | 0.01% | $92.65K |
| Tessera Therapeutics Ser D Cvt Pfd Pp | 0.01% | $89.34K |
| Arbor Bio Series C Cvt Pfd Stock Pp | 0.01% | $83.60K |
| Color Health Series E Cvt Pfd Stock Pp | 0.01% | $81.63K |
| Odyssey Therapeutics Sr B Cvt Pfd Stk Pp | 0.01% | $79.90K |
| Delfi Diagnostics CVT Prom Note PP | 0.01% | $78.28K |
| Element Biosciences Ser D-1 Cvt Pfd Pp | 0.01% | $75.24K |
| Sail Biomedicines Ser B Cvt Pfd Stock Pp | 0.01% | $75.65K |
| Element Biosciences Ser D Cvt Pfd Pp | 0.01% | $75.24K |
| Beta Bionics, Inc. | 0.01% | $71.26K |
| Avalyn Pharma Ser D Cvt Pfd Stock Pp | 0.01% | $71.75K |
| Freenome Holdings Ser D Cvt Pfd Pp | 0.01% | $69.10K |
| Radnet, Inc. | 0.01% | $62.37K |
| Mediwound Ltd. | 0.01% | $61.41K |
| Ring Therapeutics, Inc. Pp | 0.01% | $60.14K |
| Verily Life Sciences LLC Ser B Units Pp | 0.01% | $58.19K |
| Clear Labs Ser D Cvt Pfd Stock Pp | 0.01% | $57.97K |
| Mirum Pharma Escrow Indemnity PP | 0.01% | $54.61K |
| Nuvation Bio, Inc. | 0.01% | $49.00K |
| Kartos Therapeutics CVT Prom Note PP | 0.01% | $44.80K |
| Honor Technology Ser D Cvt Pfd Pp | 0.01% | $42.25K |
| Capsule Corp. Series E Cvt Pfd Stock Pp | 0.01% | $41.28K |
| Capsule Corp. Series 1-D Cvt Pfd Stock | 0.01% | $38.52K |
| Odyssey Therapeutics SER D CVT Pfd Stk PP | 0.01% | $36.99K |
| Reflexion Med CVT Note issued 081325 PP | 0.01% | $33.03K |
| Reflexion Med CVT Note issued 072525 PP | 0.01% | $33.27K |
| Reflexion Med CVT Note issued 082725 PP | 0.00% | $32.78K |
| Profoundbio Escrow Fund Payment Pp | 0.00% | $31.95K |
| Janux Therapeutics, Inc. | 0.00% | $30.65K |
| Honor Technology Ser E Cvt Pfd Stock Pp | 0.00% | $28.47K |
| Freenome Holdings Ser F Cvt Pfd Pp | 0.00% | $24.94K |
| Treeline Bio Common WTS 8/35 PP | 0.00% | $18.98K |
| Revolution Medicines, Inc. Wts 12/26 | 0.00% | $19.31K |
| Cabaletta Bio Common WTS 09/26 PP | 0.00% | $17.83K |
| Ginkgo Bioworks Holdings, Inc. | 0.00% | $13.98K |
| Chromacode INC SER AA CVT PFD STK PP | 0.00% | $9.69K |
| Odyssey Therapeutics Sr C Cvt Pfd Stk Pp | 0.00% | $7.38K |
| PROGNOMIQ INC CL A Common PP | 0.00% | $4.10K |
| Mirum Pharma Escrow Working Capital PP | 0.00% | $2.20K |
| Mirum Pharma Escrow Expense Fund PP | 0.00% | $2.20K |
| Affinivax Expense Fund Pp | 0.00% | $522 |
| Ginkgo Bioworks Hlds Ern Out Sh 800 Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 1 Pp | 0.00% | $0 |
| Affinivax Next Gen Prod Mileston Evnt Pp | 0.00% | $0 |
| Nutcracker Thera Ser C Cvt Pfd Stock Pp | 0.00% | $0 |
| Blue Marlin Therapeutics Common Stock PP | 0.00% | $8 |
| Generation Bio Co. | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr C-X Pp | 0.00% | $196 |
| Mirum Pharma Milestone $500 mil PP | 0.00% | $0 |
| Reflexion Medical Ser F Cvt Pfd Stock Pp | 0.00% | $83 |
| Odyssey Therapeutics Warrants 6/32 WRT PP | 0.00% | $0 |
| Chromacode, Inc. Pp | 0.00% | $136 |
| Profoundbio Expense Fund Payment Pp | 0.00% | $22 |
| Somalogic, Inc. Wts 8/26 | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr E-X Pp | 0.00% | $117 |
| Mirum Pharma Milestone $750 mil PP | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 700 Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 3 Pp | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr D-X Pp | 0.00% | $66 |
| Affinivax Afx3772 Milestone Event Pp | 0.00% | $0 |
| Exact Sciences Cmo Milestone Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 2 Pp | 0.00% | $0 |
| Genedx Holdings Corp. Wts 7/26 | 0.00% | $91 |
| Exact Sciences Fda Milestone Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 600 Pp | 0.00% | $0 |
QAAGZX overview: performance, fees, allocation and SEC filings